Biomx Inc PHGE-IL:Tel Aviv Stock Exchange

*Data is delayed | ILS
Last | 5:24 PM EEST
282.00quote price arrow up+38.80 (+16.17%)
Volume
90,787
52 week range
201.40 - 709.00
Loading...
  • Open267.00
  • Day High287.90
  • Day Low260.00
  • Prev Close278.80
  • 52 Week High709.00
  • 52 Week High Date04/04/22
  • 52 Week Low201.40
  • 52 Week Low Date06/12/22

Key Stats

  • Market Cap25.23M
  • Shares Out29.77M
  • 10 Day Average Volume194,203.33
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-38.63

KEY STATS

  • Open267.00
  • Day High287.90
  • Day Low260.00
  • Prev Close278.80
  • 52 Week High709.00
  • 52 Week High Date04/04/22
  • 52 Week Low201.40
  • 52 Week Low Date06/12/22
  • Market Cap25.23M
  • Shares Out29.77M
  • 10 Day Average Volume194,203.33
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-38.63

RATIOS/PROFITABILITY

  • EPS (TTM)-418.32
  • P/E (TTM)-0.67
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biomx Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage...
Russell Greig Ph.D.
Independent Chairman of the Board
Jonathan Solomon
Chief Executive Officer, Director
Marina Wolfson CPA
Chief Financial Officer
Address
22 Einstein St., Floor 5
Ness-ziona
7414001
Israel